AI Engines For more Details: Perplexity Kagi Labs You
Antioxidant Properties: Honey contains antioxidants such as flavonoids and phenolic compounds, which have been associated with reducing oxidative stress and inflammation in the body. These antioxidant properties may help protect against chronic diseases such as cardiovascular disease and cancer.
Wound Healing: Honey has been used topically for wound healing for centuries due to its antimicrobial properties. It has been shown to help promote wound healing, reduce infection risk, and accelerate tissue regeneration. Medical-grade honey, such as Manuka honey, is particularly known for its wound-healing properties.
Cough and Sore Throat Relief: Honey has been used as a home remedy for coughs and sore throats. Its soothing properties can help relieve throat irritation and cough symptoms. It is often mixed with warm water, lemon, or herbal teas for added benefits.
Gut Health: Some research suggests that honey may have prebiotic effects, promoting the growth of beneficial gut bacteria and supporting overall gut health. However, more studies are needed to fully understand its impact on the gut microbiome.
Allergy Relief: There is anecdotal evidence suggesting that consuming locally sourced honey may help alleviate allergy symptoms by exposing individuals to small amounts of pollen, potentially desensitizing them to allergens over time. However, scientific evidence supporting this claim is limited.
Energy Source: Honey is a source of carbohydrates, primarily consisting of fructose and glucose, which provide a quick energy boost. It is often used by athletes as a natural energy source before or during exercise.
Blood Sugar Control: While honey is a natural sweetener, it still contains sugars and can affect blood sugar levels. Individuals with diabetes should consume honey in moderation and monitor their blood sugar levels closely.
Weight Management: Compared to refined sugars, honey has a lower glycemic index, which means it may cause a slower and smaller increase in blood sugar levels. Some studies suggest that substituting honey for other sweeteners may help with weight management, but portion control is still important.
Rank | Probiotic | Impact |
---|---|---|
species | Escherichia coli | Reduces |
strain | Escherichia coli G3/10 | Reduces |
strain | Escherichia coli Nissle 1917 | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Allergic Rhinitis (Hay Fever) | 0.3 | 0.3 | |
Allergies | 0.5 | 0.5 | 0 |
Allergy to milk products | 0.5 | 0.3 | 0.67 |
Alzheimer's disease | 0.3 | 0.3 | |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.3 | 0.5 | -0.67 |
Ankylosing spondylitis | 0.8 | 0.8 | |
Antiphospholipid syndrome (APS) | 1 | 1 | |
Asthma | 0.5 | 0.5 | 0 |
Atrial fibrillation | 0.3 | -0.3 | |
Autism | 0.8 | 0.3 | 1.67 |
benign prostatic hyperplasia | 0.3 | 0.3 | |
Bipolar Disorder | 0.3 | 0.3 | |
Brain Trauma | 0.5 | -0.5 | |
Carcinoma | 0.3 | 0.3 | |
Celiac Disease | 1.3 | 0.3 | 3.33 |
Chronic Kidney Disease | 0.3 | 0.3 | |
Chronic Urticaria (Hives) | 0.8 | 0.8 | |
Coagulation / Micro clot triggering bacteria | 1.3 | 1.3 | |
Colorectal Cancer | 0.8 | 0.8 | |
Constipation | 0.3 | 0.3 | |
COVID-19 | 1.2 | 1.2 | |
Crohn's Disease | 0.8 | 0.8 | |
cystic fibrosis | 0.8 | 0.8 | |
deep vein thrombosis | 1.3 | 1.3 | |
Depression | 0.3 | 0.3 | 0 |
Eczema | 0.3 | 0.3 | |
Endometriosis | 0.8 | 0.8 | |
Epilepsy | 0.3 | 0.3 | |
Functional constipation / chronic idiopathic constipation | 1.3 | 1.3 | |
gallstone disease (gsd) | 0.3 | 0.3 | |
Generalized anxiety disorder | 0.8 | 0.8 | |
Hidradenitis Suppurativa | 0.5 | 0.5 | |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.5 | 0.5 | |
hyperglycemia | 0.8 | 0.8 | |
hypertension (High Blood Pressure | 0.8 | 0.5 | 0.6 |
Inflammatory Bowel Disease | 1.3 | 1.3 | |
Insomnia | 0.1 | 0.1 | |
Irritable Bowel Syndrome | 0.8 | 0.8 | |
Liver Cirrhosis | 1.3 | 0.5 | 1.6 |
Long COVID | 0.3 | 0.3 | |
Lung Cancer | 0.3 | 0.3 | |
Metabolic Syndrome | 1.3 | 0.5 | 1.6 |
Mood Disorders | 0.3 | 0.3 | 0 |
Multiple system atrophy (MSA) | 0.2 | 0.2 | |
Neuropathy (all types) | 0.3 | -0.3 | |
neuropsychiatric disorders (PANDAS, PANS) | 0.5 | 0.5 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.3 | 0.3 | |
Obesity | 0.8 | 0.5 | 0.6 |
obsessive-compulsive disorder | 1.3 | 1.3 | |
Osteoarthritis | 0.3 | 0.3 | |
Osteoporosis | 0.3 | 0.3 | |
Parkinson's Disease | 0.5 | 0.3 | 0.67 |
Polycystic ovary syndrome | 0.3 | 0.3 | |
Psoriasis | 1 | 1 | |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.8 | 0.8 | |
Rosacea | 0.2 | 0.2 | |
Sjögren syndrome | 0.3 | 0.3 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 1 | 1 | |
Stress / posttraumatic stress disorder | 1.2 | 1.2 | |
Systemic Lupus Erythematosus | 0.3 | 0.3 | |
Type 1 Diabetes | 0.3 | 0.5 | -0.67 |
Type 2 Diabetes | 1.3 | 1 | 0.3 |
Ulcerative colitis | 1.3 | 1.3 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.